Foundayo (orforglipron) is a prescription oral GLP-1 receptor agonist approved by the FDA for chronic weight management in eligible adults. Unlike injectable GLP-1 medications, Foundayo is taken as a tablet once daily and can be taken with or without food.
What Is Foundayo?
Foundayo contains orforglipron, an oral GLP-1 receptor agonist. It is approved for use with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long-term in adults with obesity or adults who are overweight and have at least one weight-related comorbid condition.
How Is Foundayo Taken?
Foundayo is taken once daily, with or without food. The FDA-approved prescribing information specifies a gradual dose-escalation schedule based on treatment response and tolerability. The available tablet strengths are 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, and 17.2 mg, with a maximum dosage of 17.2 mg once daily.
Your healthcare professional will determine the appropriate dose and whether Foundayo is suitable for you.
Foundayo Benefits
Foundayo may be an option for eligible adults seeking a daily oral GLP-1 treatment for weight management. In clinical trials supporting FDA approval, Foundayo, used alongside a reduced-calorie diet and increased physical activity, produced significantly greater weight reduction than placebo over 72 weeks.
Foundayo Side Effects
Common adverse reactions reported with Foundayo include nausea, constipation, diarrhea, vomiting, indigestion, abdominal pain, headache, abdominal distension, fatigue, burping, acid reflux, gas, and hair loss.
Foundayo also carries important warnings and contraindications. It should not be used by people with a personal or family history of medullary thyroid carcinoma (MTC) or by people with multiple endocrine neoplasia syndrome type 2 (MEN 2).
Foundayo Prescription Requirements
Foundayo is a prescription medication. A healthcare professional must evaluate your medical history, current medications, health status, and weight-management needs before prescribing treatment.
Do not use Foundayo together with another GLP-1 receptor agonist unless specifically directed by your healthcare professional.
Foundayo vs. Injectable GLP-1 Medications
One of the key differences between Foundayo and injectable GLP-1 treatments is the route of administration. Foundayo is taken as a once-daily oral tablet, while many other GLP-1-based weight-management treatments are administered by injection.
The right medication depends on your medical history, treatment goals, tolerability, and healthcare professional’s assessment.
Frequently Asked Questions
Is Foundayo FDA approved?
Yes. The FDA approved Foundayo (orforglipron) on April 1, 2026, for chronic weight management in eligible adults with obesity or overweight accompanied by at least one weight-related comorbid condition.
Is Foundayo a pill?
Yes. Foundayo is an oral tablet taken once daily. It can be taken with or without food.
What is Foundayo used for?
Foundayo is approved to reduce excess body weight and maintain weight reduction long-term in eligible adults when used together with a reduced-calorie diet and increased physical activity.
What is the active ingredient in Foundayo?
The active ingredient is orforglipron, an oral GLP-1 receptor agonist.
Do I need a prescription for Foundayo?
Yes. Foundayo is a prescription medication and should only be used under the supervision of a qualified healthcare professional.
Start With a Medical Evaluation
If you’re considering Foundayo for weight management, speak with a qualified healthcare professional to determine whether this prescription treatment is appropriate for you.
Foundayo is not right for everyone. Individual results and treatment decisions vary. Always follow your healthcare professional’s instructions and the FDA-approved prescribing information.
Reviews
There are no reviews yet.